Universitetssykehuset i Nord-Norge — Tromsø

What best describes you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Universitetssykehuset i Nord-Norge, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non Small Cell Lung Cancer Stage III · Ulcerative Colitis · NSCLC, Stage III · Lymphoma, Large B-Cell, Diffuse

Recently updated registry entries

NCT06468228 — A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent… (Active Not Recruiting)
NCT05064059 — A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in… (Completed)
NCT03260894 — Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC… (Completed)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 08, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.